Overview of Skin Elements Limited and its controlled entities

Skin Elements Limited (ASX: $SKN) and its controlled entities have reported their interim financial report for the half-year ended 31 December 2023. The company, listed on the Australian Securities Exchange under the code SKN, is a researcher and developer of the innovative proprietary SE Formula TM biotechnology. This plant-based and organic sourced SE FormulaTM is used as a base in the Company's proprietary flagship products including the SuprCuvr TGA-registered hospital-grade plant-based disinfectant, ECO-Nurture plant bio-stimulant, Invisi Shield alcohol-free natural sanitiser, Soléo Organics natural and organic sunscreen, PapayaActivs natural therapeutics skincare, and Elizabeth Jane Natural Cosmetics brand.

Executive commentary on the company's operations and financial performance

The executive commentary highlighted the company's continued focus on the development and commercialisation of the SE Formula technology brands and applications. The commentary also mentioned the ongoing development of the ECO-Nurture plant bio-stimulant and the successful testing of SuprCuvr in various sectors. Additionally, it emphasized the company's commitment to research and development, as evidenced by the R&D tax incentive grant income received during the period.

Summary of the financial report and outlook

The financial report reflects Skin Elements' dedication to the development and commercialisation of its natural products. The company's ambitions and goals are evident in its ongoing research and development efforts, as well as its pursuit of opportunities in the agriscience market. Despite the material uncertainty relating to going concern, the company remains confident in its ability to secure additional funding and generate profits from its normal course of business. Looking ahead, Skin Elements aims to continue its focus on the development and commercialisation of its natural anti-microbial technology and expand its range of natural and organic products.